Pulike Biological Engineering, Inc. (SHA:603566)

China · Delayed Price · Currency is CNY

13.84

+0.49 (3.67%)

Mar 6, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Pig Vaccine	336.24M
Poultry Vaccines and Antibodies	429.39M
Vaccines for Ruminants	2.56M
Pets	14.42M
Chemical	222.78M
Functional Health Products, Etc.	18.65M
Technology Licensing or Transfer Income	9.83M
Total	1.03B

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Northeast China	128.40M						-	-	-	-
North China	92.09M						-	-	-	-
East China	339.85M						-	-	-	-
South China	128.93M						-	-	-	-
Central China	187.48M						-	-	-	-
Northwest China	29.73M						-	-	-	-
Southwest China	105.71M						-	-	-	-
Overseas	21.68M						-	-	-	-
China	-						608.06M	529.90M	583.10M	478.14M
China Growth	-						14.75%	-9.12%	21.95%	0.51%
Total	1.03B						608.06M	529.90M	583.10M	478.14M
Total Growth	-						14.75%	-9.12%	21.95%	0.51%

Source: S&P Global Market Intelligence.